Conditioning Side Effects in the Stem Cell Transplant
Learning Objectives
To Prepare House Officers for potential complications they might encounter when cross-covering the Stem Cell Transplant Unit
Understand the potential neurotoxicity and initial management for Busulfan & Cyclosporine
Know the general fluid management for Cyclophosphamide administration & the potential for iatrogenic hyponatremia
Learn why it is bad to canoodle with someone receiving Thiotepa
Understand the common side effects of serotherapy
Author(s)
Steven Margossian, MD, PhD
Senior Medical Director | Nuvalent
Assistant Professor of Pediatrics | Harvard Medical School
Traci Wolbrink, MD, MPH
Co-Director, OPENPediatrics; Co-Director, Center for Educational Excellence and Innovation; Program Director, Pediatric Critical Care Medicine Fellowship; Senior Associate in Critical Care Medicine | Boston Children’s Hospital
Associate Professor of Anaesthesia | Harvard Medical School
Mollie Grunat
Resident Doctor | Thomas Jefferson University Hospitals
Kristan Scott, MD
Attending Physician, Division of Neonatology | Children's Hospital of Philadelphia.
Katherine R. Schlosser Metitri, MD
Pediatric Critical Care Specialist | Columbia University
Vice President, Operations | NewYork-Presbyterian Morgan Stanley Children’s Hospital
Citation
Margossian S, Grunat MS, Scott K, Wolbrink TA, Schlosser KR. Conditioning Side Effects in Stem Cell Transplant. 4/2018. Online Video. OPENPediatrics. https://learn.openpediatrics.org/learn/course/internal/view/elearning/2863/conditioning-side-effects-in-stem-cell-transplant.